Actual Medicinal Product (AMP) Nitrazepam 5mg tablets (Mawdsley-Brooks & Company Ltd)

This product can't be added to an MCA list.

Stability Information

(Some stability information inherited from generic)

Stability
compatible_special_measures logo Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes

Protect from light Moisture sensitive medicine. Store in airtight (sealed) MCA  Manufacturer recommends storing in original container.

Provenance

This recommendation is based on the products Mogadon 5mg tablets (Mylan) and Nitrazepam 5mg tablets (Accord UK Ltd).

Generic
Nitrazepam
Formulation
Nitrazepam 5mg tablets
  • Nitrazepam
    • Nitrazepam 5mg tablets
      • Nitrazepam 5mg tablets (Mawdsley-Brooks & Company Ltd)

Alternative Suppliers (23)



Related Formulations (1)